Morgan Stanley Adjusts Price Target on Oracle to $210 From $207, Keeps Equalweight Rating

Morgan Stanley raised its price target on Oracle (ORCL) from $207 to $210, maintaining an Equalweight rating. The adjustment reflects a slight upward revision in the firm's valuation of the company. Oracle's stock price is currently at $154.04, up 5.69% in pre-market trading.

Original reporting
Published Sep 4, 2026, 9:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$ORCL
Bullish
medium confidence
Mentioned
$ORCL
Relevance
5/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ORCLBullishMed
01

Why it matters

Analyst target changes can trigger short‑term price moves, especially in pre‑market trading.

02

Market read

A modest analyst upgrade may generate brief buying interest in Oracle.

03

What to watch

No new fundamental data released; upgrade may be driven by internal model tweaks.

Relevance 5/10Novelty 6/10Timing: pre‑market today

Background

Morgan Stanley's research note adjusts Oracle's target price and maintains an equal‑weight rating.

Company-level read

Ticker impact

$ORCLBullishMedium confidence
Context

Morgan Stanley raised Oracle's price target to $210 from $210, indicating a fresh analyst upgrade.

Expected impact

Potential modest upside of 2‑4% in the next trading session.

Evidence & confidence

Target lift is modest but reflects improved outlook; traders often react to such upgrades.

Market effects

May lift sentiment for the broader enterprise‑software sector.

U.S. market focus; limited regional effect.

Minor, confined to investors tracking Oracle and peers.

Counterpoint

Target increase is modest; price may already reflect the outlook.

Key entities

  • Morgan Stanley

    Provider of the price‑target revision.

  • Oracle

    Subject of the price‑target adjustment.

Related articles

$ORCLMed

Why is Oracle stock rising today?

Oracle (ORCL) stock rose 2.0% to $157.13 on analyst upgrades and pre-earnings optimism. Morgan Stanley raised its target to $210, Bernstein reiterated Outperform, and Jefferies kept Buy but lowered target to $290. Oracle reports Q1 FY2027 results on September 10, 2026. Broader market is mixed, with S&P 500 down 0.1% and Nasdaq slightly positive.

$ORCLMedAI 8/10

Oracle Stock Is Off 59% From Its High. Why This Could Be the Best Time to Buy.

Oracle (ORCL) stock is down 59% from its high, but the company reports strong customer contracts and expects earnings growth. It anticipates adjusted EPS of $1.72-$1.76 for Q1, with revenue and earnings growth accelerating in the second half of fiscal 2027. Long-term, Oracle projects 31% and 28% annual revenue and earnings growth, respectively, through 2030. Analysts rate it a 'Strong Buy'.

$ORCLMed

Oracle Stock Surges 5.7% Against Market Trend: A Dual Play Between Fed Dovish Signals and AI Infrastructure Heavy Burdens

Oracle (ORCL) rose 5.7% on September 3, driven by Fed comments suggesting a potential pause in rate hikes. The company's heavy debt burden makes it sensitive to interest rates. Oracle's stock has fallen 55% from its peak, but revenue grew 17% and cloud infrastructure revenue increased 75% in fiscal 2026. The company's valuation has become more attractive, with a forward P/E of 17.

$ORCLMed

Oracle expands AWS partnership, adds quantum computing deal

Oracle and AWS expanded their partnership, launching Oracle Exadata Database Service on AWS and adding quantum computing capabilities via a deal with Quantinuum. Oracle's stock rose 0.31% to $153.76. The service is now available in 22 AWS regions, and Oracle announced new AI applications for HR and healthcare. Oracle's next earnings report is expected on September 8, 2026, with projected EPS of $1.67 and revenue of $19.13 billion.

$ORCLMed

Why Is Oracle Stock Up Today?

Oracle Corp (ORCL) rose 5.7% after Fed Governor Christopher Waller suggested keeping interest rates steady, reducing market expectations of a rate hike. Oracle's significant debt load makes it sensitive to rate changes, with the company raising $43B in bonds last year and planning further debt and equity raises.

$ORCLMed

Larry Ellison Passes Jensen Huang For 8th-Richest As Oracle Shares Soar

Oracle's stock rose 6.4% to $155 per share, increasing founder Larry Ellison's net worth to $200.2 billion, surpassing Nvidia CEO Jensen Huang. Ellison owns 40% of Oracle, while Huang's wealth is tied to his 3% stake in Nvidia. Oracle's stock is still down 30% year-over-year. Oracle's next earnings report is scheduled for next Thursday.